SEC Form 4/A · accession 0000899243-15-006923
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Dennis D Kim
Officer — Chief Medical Officer
Period of report
Sep 14, 2015
Accepted (ET)
Oct 20, 2015 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2015 | S | 593 | $40.00 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed to disclose that the sale of these shares reported in the original Form 4 by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2015 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.